Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>		A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/13543776.2020.1772231

http://scihub22266oqcxt.onion/10.1080/13543776.2020.1772231
suck pdf from google scholar
32429703!ä!32429703

suck abstract from ncbi


Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32429703.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid32429703      Expert+Opin+Ther+Pat 2020 ; 30 (8): 567-579
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review #MMPMID32429703
  • Nascimento Junior JAC; Santos AM; Quintans-Junior LJ; Walker CIB; Borges LP; Serafini MR
  • Expert Opin Ther Pat 2020[Aug]; 30 (8): 567-579 PMID32429703show ga
  • INTRODUCTION: Coronavirus has been responsible for several virus outbreaks since 2003, caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative agent of coronavirus disease in 2019. COVID-19 has become a global public health emergency because of its high virulence and mortality capacity. This patent review aims to provide an overview of the patents that present possible treatments for SARS-CoV-1, SARS-CoV-2 and MERS-CoV. AREAS COVERED: To treat SARS, MERS and SARS-CoV-2, researchers have filed patents for a number of therapeutic agents. Most of the treatments found were protease inhibitors aimed at proteases such as PLpro, 3 CLpro, RNA helicase, and Spike protein, or used monoclonal antibodies and interferons. In addition, the use of Chinese folk medicine and its multitude of medicinal plants with strong antiviral properties was reinforced. Thus, these therapies used in previous epidemics can serve as an aid in the new pandemic by SARS-CoV-2 and be a starting point for new treatments. EXPERT OPINION: The various antiviral alternatives presented in this review offer therapeutic options to fight coronavirus infections. If shown to be effective, these drugs may be extremely important in the current pandemic.
  • |*Patents as Topic[MESH]
  • |Animals[MESH]
  • |Antiviral Agents/adverse effects/*therapeutic use[MESH]
  • |Betacoronavirus/*drug effects/pathogenicity[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Coronavirus Infections/diagnosis/*drug therapy/virology[MESH]
  • |Drug Development[MESH]
  • |Drug Discovery[MESH]
  • |Host-Pathogen Interactions[MESH]
  • |Humans[MESH]
  • |Middle East Respiratory Syndrome Coronavirus/*drug effects/pathogenicity[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/diagnosis/*drug therapy/virology[MESH]
  • |SARS-CoV-2[MESH]
  • |Severe Acute Respiratory Syndrome/diagnosis/*drug therapy/virology[MESH]
  • |Severe acute respiratory syndrome-related coronavirus/*drug effects/pathogenicity[MESH]


  • DeepDyve
  • Pubget Overpricing

    • suck abstract from ncbi

    Linkout box